Routine protamine after TAVI may cut bleeding risk
NCT ID NCT05774691
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 39 times
Summary
This study compared giving protamine routinely to all patients after TAVI versus giving it only when needed. The goal was to see if routine use lowers the chance of death or major bleeding within 30 days. About 1000 adults undergoing TAVI took part. The approach aims to improve safety after heart valve replacement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.S.Z. Aalst
Aalst, Belgium
-
Amsterdam University Medical Center
Amsterdam, Netherlands
-
Leiden University Medical Center
Leiden, South Holland, Netherlands
-
Maastricht UMC
Maastricht, Limburg, Netherlands
-
St. Antonius Hospital
Nieuwegein, Utrecht, Netherlands
-
University Hospitals Leuven
Leuven, Belgium
Conditions
Explore the condition pages connected to this study.